Prognostic and predictive role of DNA mismatch repair status in stage II‐III colorectal cancer: A systematic review and meta‐analysis
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Prognostic and predictive role of DNA mismatch repair status in stage II‐III colorectal cancer: A systematic review and meta‐analysis
Authors
Keywords
-
Journal
CLINICAL GENETICS
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2019-08-21
DOI
10.1111/cge.13628
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Molecular subtypes in early colorectal cancer associated with clinical features and patient prognosis
- (2018) M. Gil-Raga et al. Clinical & Translational Oncology
- Role of Deficient DNA Mismatch Repair Status in Patients With Stage III Colon Cancer Treated With FOLFOX Adjuvant Chemotherapy
- (2018) Aziz Zaanan et al. JAMA Oncology
- Systematic immunohistochemical screening for mismatch repair and ERCC1 gene expression from colorectal cancers in China: Clinicopathological characteristics and effects on survival
- (2017) Pan Li et al. PLoS One
- Evidence for an Association of ERCC1 Expression and Mismatch Repair Status with Overall Survival in Colorectal Cancer Patients
- (2017) Pan Li et al. Oncology Research and Treatment
- Microsatellite Instability was not Associated with Survival in Stage III Colon Cancer Treated with Adjuvant Chemotherapy of Oxaliplatin and Infusional 5-Fluorouracil and Leucovorin (FOLFOX)
- (2016) Jeong Eun Kim et al. ANNALS OF SURGICAL ONCOLOGY
- Effects of microsatellite instability on recurrence patterns and outcomes in colorectal cancers
- (2016) Chang Gon Kim et al. BRITISH JOURNAL OF CANCER
- Cancer statistics in China, 2015
- (2016) Wanqing Chen et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Prognostic and predictive value of extendedRASmutation and mismatch repair status in stage III colorectal cancer
- (2016) Yusuke Sasaki et al. CANCER SCIENCE
- Colorectal Tumors From Different Racial and Ethnic Minorities Have Similar Rates of Mismatch Repair Deficiency
- (2016) Shivali Berera et al. Clinical Gastroenterology and Hepatology
- Clinical, histological, and molecular risk factors for cancer recurrence in patients with stage II colon cancer
- (2016) Yann Touchefeu et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Prognostic Value ofBRAF and KRAS Mutations in MSI and MSS Stage III Colon Cancer
- (2016) Julien Taieb et al. JNCI-Journal of the National Cancer Institute
- Efficacy of Adjuvant Chemotherapy in Colon Cancer With Microsatellite Instability: A Large Multicenter AGEO Study
- (2016) David Tougeron et al. JNCI-Journal of the National Cancer Institute
- Coexistence of MSI with KRAS mutation is associated with worse prognosis in colorectal cancer
- (2016) Jing Hu et al. MEDICINE
- Immunohistochemical staining for p16 and BRAFV600E is useful to distinguish between sporadic and hereditary (Lynch syndrome-related) microsatellite instable colorectal carcinomas
- (2016) Florence Boissière-Michot et al. VIRCHOWS ARCHIV
- Prognostic Value ofBRAF and KRAS Mutations in MSI and MSS Stage III Colon Cancer
- (2016) Julien Taieb et al. JNCI-Journal of the National Cancer Institute
- Efficacy of Adjuvant Chemotherapy in Colon Cancer With Microsatellite Instability: A Large Multicenter AGEO Study
- (2016) David Tougeron et al. JNCI-Journal of the National Cancer Institute
- Current and future biomarkers in the treatment of colorectal cancer
- (2016) Pieter-Jan Cuyle et al. ACTA CLINICA BELGICA
- Defective Mismatch Repair Status was not Associated with DFS and OS in Stage II Colon Cancer Treated with Adjuvant Chemotherapy
- (2015) Jeong Eun Kim et al. ANNALS OF SURGICAL ONCOLOGY
- Systematic review of the predictive effect of MSI status in colorectal cancer patients undergoing 5FU-based chemotherapy
- (2015) Elizabeth M Webber et al. BMC CANCER
- Molecular Markers Identify Subtypes of Stage III Colon Cancer Associated With Patient Outcomes
- (2015) Frank A. Sinicrope et al. GASTROENTEROLOGY
- Adjuvant Fluorouracil, Leucovorin, and Oxaliplatin in Stage II to III Colon Cancer: Updated 10-Year Survival and Outcomes According toBRAFMutation and Mismatch Repair Status of the MOSAIC Study
- (2015) Thierry André et al. JOURNAL OF CLINICAL ONCOLOGY
- The Prognostic Value of Microsatellite Instability,KRAS,BRAFandPIK3CAMutations in Stage II Colon Cancer Patients
- (2015) F Jeroen Vogelaar et al. MOLECULAR MEDICINE
- Genomic Classifier ColoPrint Predicts Recurrence in Stage II Colorectal Cancer Patients More Accurately Than Clinical Factors
- (2015) S. Kopetz et al. ONCOLOGIST
- The Global Burden of Cancer 2013
- (2015) Christina Fitzmaurice et al. JAMA Oncology
- Risk of recurrence in patients with colon cancer stage II and III: A systematic review and meta-analysis of recent literature
- (2014) Camilla Böckelman et al. ACTA ONCOLOGICA
- Prognosis of stage II and III colon cancer treated with adjuvant 5-fluorouracil or FOLFIRI in relation to microsatellite status: results of the PETACC-3 trial
- (2014) D. Klingbiel et al. ANNALS OF ONCOLOGY
- Molecular patterns in deficient mismatch repair colorectal tumours: results from a French prospective multicentric biological and genetic study
- (2014) M-C Etienne-Grimaldi et al. BRITISH JOURNAL OF CANCER
- A Further Investigation of Combined Mismatch Repair and BRAFV600E Mutation Specific Immunohistochemistry as a Predictor of Overall Survival in Colorectal Carcinoma
- (2014) Nathan Luey et al. PLoS One
- Survival in stage II/III colorectal cancer is independently predicted by chromosomal and microsatellite instability, but not by specific driver mutations
- (2013) Dmitri Mouradov et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Prognostic Value of Mucinous Histology Depends on Microsatellite Instability Status in Patients with Stage III Colon Cancer Treated with Adjuvant FOLFOX Chemotherapy: A Retrospective Cohort Study
- (2013) Se Hyun Kim et al. ANNALS OF SURGICAL ONCOLOGY
- Management of stage II colon cancer - the use of molecular biomarkers for adjuvant therapy decision
- (2013) Marisa Donada et al. BMC GASTROENTEROLOGY
- ERCC1, defective mismatch repair status as predictive biomarkers of survival for stage III colon cancer patients receiving oxaliplatin-based adjuvant chemotherapy
- (2013) P Li et al. BRITISH JOURNAL OF CANCER
- Molecular Pathways: Microsatellite Instability in Colorectal Cancer: Prognostic, Predictive, and Therapeutic Implications
- (2012) F. A. Sinicrope et al. CLINICAL CANCER RESEARCH
- Deficient mismatch repair phenotype is a prognostic factor for colorectal cancer in elderly patients
- (2012) Thomas Aparicio et al. DIGESTIVE AND LIVER DISEASE
- Microsatellite instability status does not predict total lymph node or negative lymph node retrieval in stage III colon cancer
- (2012) Erin MacQuarrie et al. HUMAN PATHOLOGY
- Evaluation of Guanylyl Cyclase C Lymph Node Status for Colon Cancer Staging and Prognosis
- (2011) Daniel J. Sargent et al. ANNALS OF SURGICAL ONCOLOGY
- Defective Mismatch Repair Status as a Prognostic Biomarker of Disease-Free Survival in Stage III Colon Cancer Patients Treated with Adjuvant FOLFOX Chemotherapy
- (2011) A. Zaanan et al. CLINICAL CANCER RESEARCH
- Epithelial-Mesenchymal Transition (EMT) Protein Expression in a Cohort of Stage II Colorectal Cancer Patients With Characterized Tumor Budding and Mismatch Repair Protein Status
- (2011) David Kevans et al. INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY
- Value of Mismatch Repair, KRAS, and BRAF Mutations in Predicting Recurrence and Benefits From Chemotherapy in Colorectal Cancer
- (2011) Gordon Hutchins et al. JOURNAL OF CLINICAL ONCOLOGY
- Microsatellite Instability and Loss of Heterozygosity at Chromosomal Location 18q: Prospective Evaluation of Biomarkers for Stages II and III Colon Cancer—A Study of CALGB 9581 and 89803
- (2011) Monica M. Bertagnolli et al. JOURNAL OF CLINICAL ONCOLOGY
- Capecitabine Plus Oxaliplatin Compared With Fluorouracil and Folinic Acid As Adjuvant Therapy for Stage III Colon Cancer
- (2011) Daniel G. Haller et al. JOURNAL OF CLINICAL ONCOLOGY
- Association of Obesity With DNA Mismatch Repair Status and Clinical Outcome in Patients With Stage II or III Colon Carcinoma Participating in NCCTG and NSABP Adjuvant Chemotherapy Trials
- (2011) Frank A. Sinicrope et al. JOURNAL OF CLINICAL ONCOLOGY
- Mismatch repair status in sporadic colorectal cancer: Immunohistochemistry and microsatellite instability analyses
- (2011) Yong Sik Yoon et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- DNA Mismatch Repair Status and Colon Cancer Recurrence and Survival in Clinical Trials of 5-Fluorouracil-Based Adjuvant Therapy
- (2011) F. A. Sinicrope et al. JNCI-Journal of the National Cancer Institute
- Microsatellite instability as a marker of prognosis and response to therapy: A meta-analysis of colorectal cancer survival data
- (2010) Cecilia Guastadisegni et al. EUROPEAN JOURNAL OF CANCER
- Defective Mismatch Repair As a Predictive Marker for Lack of Efficacy of Fluorouracil-Based Adjuvant Therapy in Colon Cancer
- (2010) Daniel J. Sargent et al. JOURNAL OF CLINICAL ONCOLOGY
- Clinical significance of microsatellite instability for stage II or III colorectal cancer following adjuvant therapy with doxifluridine
- (2010) Byung Woog Kang et al. MEDICAL ONCOLOGY
- Microsatellite instability in colorectal cancer and association with thymidylate synthase and dihydropyrimidine dehydrogenase expression
- (2009) Søren A Jensen et al. BMC CANCER
- Does microsatellite instability predict the efficacy of adjuvant chemotherapy in colorectal cancer? A systematic review with meta-analysis
- (2009) Gaëtan Des Guetz et al. EUROPEAN JOURNAL OF CANCER
- Improved Overall Survival With Oxaliplatin, Fluorouracil, and Leucovorin As Adjuvant Treatment in Stage II or III Colon Cancer in the MOSAIC Trial
- (2009) Thierry André et al. JOURNAL OF CLINICAL ONCOLOGY
- Molecular Basis of Colorectal Cancer
- (2009) Sanford D. Markowitz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prognostic Significance of Defective Mismatch Repair and BRAF V600E in Patients with Colon Cancer
- (2008) A. J. French et al. CLINICAL CANCER RESEARCH
- Microsatellite instability in sporadic colon carcinomas has no independent prognostic value in a Belgian study population
- (2008) Vanessa Deschoolmeester et al. EUROPEAN JOURNAL OF CANCER
- The efficacy of adjuvant chemotherapy with 5-fluorouracil in colorectal cancer depends on the mismatch repair status
- (2008) Rodrigo Jover et al. EUROPEAN JOURNAL OF CANCER
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now